Preclinical Insights into ANXO-125 as a Promising Anxiolytic Herbal Formulation

Background: Anxiety disorders are among the most prevalent mental health conditions worldwide, affecting millions of individuals and significantly impairing quality of life. Although conventional anxiolytic medications are effective, their long-term use is often associated with adverse effects such as sedation, cognitive impairment, dependence, and other systemic complications. This has increased interest in safer, plant-based therapeutic alternatives. ANXO-125, a novel polyherbal formulation containing Centella asiatica L. (CA), Nardostachys jatamansi DC, Tinospora cordifolia (Willd.) Hook, Terminalia chebula Retz, and Trilokya Vijaya Vati , has been developed based on their documented neuroprotective, antioxidant, adaptogenic, and anxiolytic properties. The present study was undertaken to evaluate the anxiolytic potential of ANXO-125 in experimental animal models and to explore its suitability as a natural therapeutic option for anxiety disorders. Aim: The anxiolytic effect of the test formulation, ANXO-125 containing a combination of different herbs, was investigated in this study. Methods: Female Swiss Albino mice, divided into five groups were examined for toxicity by the acute oral toxicity test, whereas the changes in their anxiety-like behaviours were studied through the Elevated plus maze, social interaction and marble burying test. At the end of these three experiments, mice were sacrificed and their brain homogenates examined for neurotransmitter release. Results: For two out of the three behavioural tests, ANXO-125 at higher doses was observed to exhibit anxiolytic effects, comparable to the standard, Diazepam. In the final behavioural test, where observations were taken for a longer period of 30 minutes, the lower and higher doses were inferred to be strong anxiolytics, similar to the standard. With the estimation of neurotransmitter release, ANXo-125 was confirmed as herbal anxiolytic agent. Conclusion: The study concludes that ANXO

View article page

Download PDF